Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate

Journal of Virology

Volumn 84, Issue 1, 2010, Pages 492-502

  Prado, Julia G ^a,f   Prendergast, Andrew ^a   Thobakgale, Christina ^b   Molina, Claudia ^a   Tudor Williams, Gareth ^c   Ndung'u, Thumbi ^b   Walker, Bruce D ^a,d,e   Goulder, Philip ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; HLA B ANTIGEN; NEF PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CLADISTICS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDEL MUTATION; INFANT; INFECTION CONTROL; MOTHER CHILD RELATION; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS CARRIER; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KINETICS; MUTATION; SOUTH AFRICA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 72849140105     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01743-09     Document Type: Article

References (44)

1. Arien, K. K., R. M. Troyer, Y. Gali, R. L. Colebunders, E. J. Arts, and G. Vanham. 2005. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19:1555-1564.
2. Bailey, J. R., K. O'Connell, H. C. Yang, Y. Han, J. Xu, B. Jilek, T. M. Williams, S. C. Ray, R. F. Siliciano, and J. N. Blankson. 2008. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J. Virol. 82:7395-7410.
3. Bjorndal, A., H. Deng, M. Jansson, J. R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D. R. Littman, and E. M. Fenyo. 1997. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:7478-7487.
4. Brockman, M. A., A. Schneidewind, M. Lahaie, A. Schmidt, T. Miura, I. Desouza, F. Ryvkin, C. A. Derdeyn, S. Allen, E. Hunter, J. Mulenga, P. A. Goepfert, B. D. Walker, and T. M. Allen. 2007. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81:12608-12618.
5. Choge, I., T. Cilliers, P. Walker, N. Taylor, M. Phoswa, T. Meyers, J. Viljoen, A. Violari, G. Gray, P. L. Moore, M. Papathanosopoulos, and L. Morris. 2006. Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression. AIDS Res. Hum. Retrovir. 22:458-465.
6. Chopera, D. R., Z. Woodman, K. Mlisana, M. Mlotshwa, D. P. Martin, C. Seoighe, F. Treurnicht, D. A. de Rosa, W. Hide, S. A. Karim, C. M. Gray, and C. Williamson. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4:e1000033.
7. Church, J. D., W. Huang, A. Mwatha, J. Toma, E. Stawiski, D. Donnell, L. A. Guay, F. Mmiro, P. Musoke, J. B. Jackson, N. Parkin, and S. H. Eshleman. 2008. HIV-1 tropism and survival in vertically infected Ugandan infants. J. Infect. Dis. 197:1382-1388.
8. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. 2008. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 22:97-105.
9. Crawford, H., W. Lumm, A. Leslie, M. Schaefer, D. Boeras, J. G. Prado, J. Tang, P. Farmer, T. Ndung'u, S. Lakhi, J. Gilmour, P. Goepfert, B. D. Walker, R. Kaslow, J. Mulenga, S. Allen, P. J. Goulder, and E. Hunter. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206:909-921.
10. Crawford, H., J. G. Prado, A. Leslie, S. Hue, I. Honeyborne, S. Reddy, M. van der Stok, Z. Mncube, C. Brander, C. Rousseau, J. I. Mullins, R. Kaslow, P. Goepfert, S. Allen, E. Hunter, J. Mulenga, P. Kiepiela, B. D. Walker, and P. J. Goulder. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLAB* 5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81:8346-8351.
11. Dalmau, J., M. C. Puertas, M. Azuara, A. Marino, N. Frahm, B. Mothe, N. Izquierdo-Useros, M. J. Buzon, R. Paredes, L. Matas, T. M. Allen, C. Brander, C. Rodrigo, B. Clotet, and J. Martinez-Picado. 2009. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. Clin. Infect. Dis. 48:229-238.
12. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
13. + T cells. Nature 417:95-98.
14. Goepfert, P. A., W. Lumm, P. Farmer, P. Matthews, A. Prendergast, J. M. Carlson, C. A. Derdeyn, J. Tang, R. A. Kaslow, A. Bansal, K. Yusim, D. Heckerman, J. Mulenga, S. Allen, P. J. Goulder, and E. Hunter. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 205:1009-1017.
15. Goetz, M. B., R. Leduc, J. R. Kostman, A. M. Labriola, Y. Lie, J. Weidler, E. Coakley, M. Bates, and R. Luskin-Hawk. 2009. Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection. J. Acquir. Immune Defic. Syndr. 50:259-266.
16. Goulder, P. J., and D. I. Watkins. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol.
17. HIV Paediatric Prognostic Markers Collaborative Study. 2006. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS 20:1289-1294.
18. Huang, S., J. Dunkley-Thompson, Y. Tang, E. A. Macklin, J. Steel-Duncan, I. Singh-Minott, E. G. Ryland, M. Smikle, B. D. Walker, C. D. Christie, and M. E. Feeney. 2008. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J. Immunol. 181:8103-8111.
19. Ioannidis, J. P., A. Tatsioni, E. J. Abrams, M. Bulterys, R. W. Coombs, J. J. Goedert, B. T. Korber, M. J. Mayaux, L. M. Mofenson, J. Moye, Jr., M. L. Newell, D. E. Shapiro, J. P. Teglas, B. Thompson, and J. Wiener. 2004. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 18:99-108.
20. Kawashima, Y., K. Pfafferott, J. Frater, P. Matthews, R. Payne, M. Addo, H. Gatanaga, M. Fujiwara, A. Hachiya, H. Koizumi, N. Kuse, S. Oka, A. Duda, A. Prendergast, H. Crawford, A. Leslie, Z. Brumme, C. Brumme, T. Allen, C. Brander, R. Kaslow, J. Tang, E. Hunter, S. Allen, J. Mulenga, S. Branch, T. Roach, M. John, S. Mallal, A. Ogwu, R. Shapiro, J. G. Prado, S. Fidler, J. Weber, O. G. Pybus, P. Klenerman, T. Ndung'u, R. Phillips, D. Heckerman, P. R. Harrigan, B. D. Walker, M. Takiguchi, and P. Goulder. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 70:170-174.
21. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53.
22. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
23. Kourtis, A. P., C. Ibegbu, A. J. Nahmias, F. K. Lee, W. S. Clark, M. K. Sawyer, and S. Nesheim. 1996. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335:1431-1436.
24. Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, M. Altfeld, C. Brander, C. Dixon, D. Ramduth, P. Jeena, S. A. Thomas, A. St John, T. A. Roach, B. Kupfer, G. Luzzi, A. Edwards, G. Taylor, H. Lyall, G. Tudor-Williams, V. Novelli, J. Martinez-Picado, P. Kiepiela, B. D. Walker, and P. J. Goulder. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289.
25. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, D. L. Panicali, and J. L. Sullivan. 1995. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154:433-443.
26. Mariani, R., F. Kirchhoff, T. C. Greenough, J. L. Sullivan, R. C. Desrosiers, and J. Skowronski. 1996. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70:7752-7764. (Pubitemid 26339081)
27. Martinez-Picado, J., J. G. Prado, E. E. Fry, K. Pfafferott, A. Leslie, S. Chetty, C. Thobakgale, I. Honeyborne, H. Crawford, P. Matthews, T. Pillay, C. Rousseau, J. I. Mullins, C. Brander, B. D. Walker, D. I. Stuart, P. Kiepiela, and P. Goulder. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
28. Miura, T., M. A. Brockman, A. Schneidewind, M. Lobritz, F. Pereyra, A. Rathod, B. L. Block, Z. L. Brumme, C. J. Brumme, B. Baker, A. C. Rothchild, B. Li, A. Trocha, E. Cutrell, N. Frahm, C. Brander, I. Toth, E. J. Arts, T. M. Allen, and B. D. Walker. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J. Virol. 83:2743-2755.
29. Mphatswe, W., N. Blanckenberg, G. Tudor-Williams, A. Prendergast, C. Thobakgale, N. Mkhwanazi, N. McCarthy, B. D. Walker, P. Kiepiela, and P. Goulder. 2007. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS 21:1253-1261.
30. Muench, L. R. A. H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
31. Papasavvas, E., J. K. Sandberg, R. Rutstein, E. C. Moore, A. Mackiewicz, B. Thiel, M. Pistilli, R. R. June, K. A. Jordan, R. Gross, V. C. Maino, D. F. Nixon, and L. J. Montaner. 2003. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. J. Infect. Dis. 188:873-882.
32. + T-cell epitope in p1 Gag protein. J. Virol. 83:1018-1025.
33. + T-cell counts but persistent virologic failure. Clin. Infect. Dis. 41:729-737.
34. Prendergast, A., W. Mphatswe, G. Tudor-Williams, M. Rakgotho, V. Pillay, C. Thobakgale, N. McCarthy, L. Morris, B. D. Walker, and P. Goulder. 2008. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS 22:1333-1343.
35. Prendergast, A., G. Tudor-Williams, P. Jeena, S. Burchett, and P. Goulder. 2007. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 370:68-80. (Pubitemid 47018314)
36. Quinones-Mateu, M. E., S. C. Ball, A. J. Marozsan, V. S. Torre, J. L. Albright, G. Vanham, G. van Der Groen, R. L. Colebunders, and E. J. Arts. 2000. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J. Virol. 74:9222-9233.
37. Repits, J., M. Oberg, J. Esbjornsson, P. Medstrand, A. Karlsson, J. Albert, E. M. Fenyo, and M. Jansson. 2005. Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. J. Gen. Virol. 86:2859-2869.
38. Rouet, F., C. Sakarovitch, P. Msellati, N. Elenga, C. Montcho, I. Viho, S. Blanche, C. Rouzioux, F. Dabis, and V. Leroy. 2003. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 112:e289.
39. Schneidewind, A., M. A. Brockman, R. Yang, R. I. Adam, B. Li, S. Le Gall, C. R. Rinaldo, S. L. Craggs, R. L. Allgaier, K. A. Power, T. Kuntzen, C. S. Tung, M. X. LaBute, S. M. Mueller, T. Harrer, A. J. McMichael, P. J. Goulder, C. Aiken, C. Brander, A. D. Kelleher, and T. M. Allen. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81:12382-12393.
40. Schneidewind, A., Y. Tang, M. A. Brockman, E. G. Ryland, J. Dunkley- Thompson, J. C. Steel-Duncan, M. A. St John, J. A. Conrad, S. A. Kalams, F. Noel, T. M. Allen, C. D. Christie, and M. E. Feeney. 2009. Maternal transmission of HIV escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J. Virol. 83:8616-8627.
41. Thobakgale, C. F., A. Prendergast, H. Crawford, N. Mkhwanazi, D. Ramduth, S. Reddy, C. Molina, Z. Mncube, A. Leslie, J. Prado, F. Chonco, W. Mphatshwe, G. Tudor-Williams, P. Jeena, N. Blanckenberg, K. Dong, P. Kiepiela, H. Coovadia, T. Ndung'u, B. D. Walker, and P. J. Goulder. 2009. Impact of Hla in mother and child on pediatric HIV-1 disease progression. J. Virol. 83:10234-10244.
42. + T-cell activity is detectable from birth in the majority of in utero-infected infants. J. Virol. 81:12775-12784.
43. Troyer, R. M., K. R. Collins, A. Abraha, E. Fraundorf, D. M. Moore, R. W. Krizan, Z. Toossi, R. L. Colebunders, M. A. Jensen, J. I. Mullins, G. Vanham, and E. J. Arts. 2005. Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J. Virol. 79:9006-9018.
44. Walker, P. R., M. Ketunuti, I. A. Choge, T. Meyers, G. Gray, E. C. Holmes, and L. Morris. 2007. Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children. AIDS Res. Hum. Retrovir. 23:204-215.